These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 17395629

  • 21. Permissive role of nitric oxide in macula densa control of renin secretion.
    Castrop H, Schweda F, Mizel D, Huang Y, Briggs J, Kurtz A, Schnermann J.
    Am J Physiol Renal Physiol; 2004 May; 286(5):F848-57. PubMed ID: 15075180
    [Abstract] [Full Text] [Related]

  • 22. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
    Banting JD, Friberg P, Adams MA.
    J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
    [Abstract] [Full Text] [Related]

  • 23. [Vasoactive peptides and the development of renal sclerosis: contribution of transgenes].
    Dussaule JC, Boffa JJ, Tharaux PL, Flamant M, Fakhouri F, Chatziantoniou C.
    J Soc Biol; 2002 Aug; 196(4):275-80. PubMed ID: 12645295
    [Abstract] [Full Text] [Related]

  • 24. Erythropoietin-induced excessive erythrocytosis activates the tissue endothelin system in mice.
    Quaschning T, Ruschitzka F, Stallmach T, Shaw S, Morawietz H, Goettsch W, Hermann M, Slowinski T, Theuring F, Hocher B, Lüscher TF, Gassmann M.
    FASEB J; 2003 Feb; 17(2):259-61. PubMed ID: 12490547
    [Abstract] [Full Text] [Related]

  • 25. Vascular endothelin-1 gene expression and synthesis and effect on renal type I collagen synthesis and nephroangiosclerosis during nitric oxide synthase inhibition in rats.
    Tharaux PL, Chatziantoniou C, Casellas D, Fouassier L, Ardaillou R, Dussaule JC.
    Circulation; 1999 Apr 27; 99(16):2185-91. PubMed ID: 10217661
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Transgenic rats expressing the human ET-2 gene: a model for the study of endothelin actions in vivo.
    Liefeldt L, Schönfelder G, Böcker W, Hocher B, Talsness CE, Rettig R, Paul M.
    J Mol Med (Berl); 1999 Jul 27; 77(7):565-74. PubMed ID: 10494802
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Chronic blockade of nitric oxide synthesis increases urinary endothelin-1 excretion.
    Nakamura T, Ohyama Y, Masuda H, Kurashina T, Saito Y, Kato T, Sumino H, Sato K, Sakamaki T, Sasaki A, Nagai R.
    J Hypertens; 1997 Apr 27; 15(4):373-81. PubMed ID: 9211172
    [Abstract] [Full Text] [Related]

  • 33. L-arginine supplementation abolishes the blood pressure and endothelin response to chronic increases in plasma sFlt-1 in pregnant rats.
    Murphy SR, LaMarca B, Cockrell K, Arany M, Granger JP.
    Am J Physiol Regul Integr Comp Physiol; 2012 Jan 15; 302(2):R259-63. PubMed ID: 22071155
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effects of endothelin-induced nitric oxide on venous circulation and renal water-electrolyte handling.
    Ota K, Kimura T, Shoji M, Ota M, Funyu T, Mori T, Sahata T.
    J Cardiovasc Pharmacol; 1998 Jan 15; 31 Suppl 1():S128-32. PubMed ID: 9595420
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.